This protocol covers the acute management of migraine without aura specifically in paediatric patients — those under 18 years of age — where age and body weight directly shape which analgesic agents are appropriate.
The patient is under 18 years of age presenting with an acute migraine without aura episode. Age is the defining factor: management differs meaningfully from adult practice, both in agent selection and in how dosing is calculated.
Acute attacks in this age group are managed with oral analgesic therapy — choice of agent depends on the child's age — with specific anti-emetic guidance when nausea or vomiting is present. The complete agent selection, sequencing, and weight-based protocol is available in the full regimen.
DOI: 10.1177/2514183X1882337
Migraine attacks in children are treated with ibuprofen 10 mg/kg body weight (BW), ASA (500 mg) or paracetamol 15 mg/kg BW (second choice).
If anti-emetics are necessary, domperidone should be used and not metoclopramide, due to the elevated risk of acute extra-pyramidal dystonia with metoclopramide.